<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04132180</url>
  </required_header>
  <id_info>
    <org_study_id>009-2018</org_study_id>
    <nct_id>NCT04132180</nct_id>
  </id_info>
  <brief_title>Early Versus Late Upper Extremity Mobilization After Autograft</brief_title>
  <acronym>EXTREMA</acronym>
  <official_title>The EXTREMA Trial: The Impact of Early Versus Late Upper Extremity Mobilization After Split Thickness Skin Autograft on Wound Healing in Adult Burn Patients - A Single Center Non-Inferiority Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunnybrook Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sunnybrook Health Sciences Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale: There is currently no observational study or randomized clinical trial published
      evaluating the impact of early versus late mobilization in the upper extremity after split
      thickness skin autograft. As the current post-operative care protocols vary based on
      physician preference, evidence is needed to optimize post-operative rehabilitation protocols
      guided by evidence which optimize wound healing, extremity range of motion, graft site pain,
      as well as minimize risks of complications and length of stay in hospital.

      Objective: To determine if early mobilization is non-inferior to late mobilization of the
      upper extremity after split thickness skin autograft with regards to wound healing measured
      as percent graft take on post-operative day 5 in adult burn patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 14, 2018</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wound healing</measure>
    <time_frame>Post-operative day 5</time_frame>
    <description>Percent graft take</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Wound healing</measure>
    <time_frame>Post-operative day 14</time_frame>
    <description>Percent graft take</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative clinical outcomes</measure>
    <time_frame>Post-operative day 5 and 14</time_frame>
    <description>Elbow range of motion measured using a goniometer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative clinical outcomes</measure>
    <time_frame>Post-operative day 5 and 14</time_frame>
    <description>Graft site pain measured using visual analogue scale (0 - no pain to 10 - worst possible pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative complications</measure>
    <time_frame>Acute hospital stay, up to one year</time_frame>
    <description>Local complications (seroma, hematoma, infection, graft loss) and systemic complications (infection, deep vein thrombosis, pulmonary embolism, myocardial infarction, mortality).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discharge outcome - disposition</measure>
    <time_frame>Acute hospital stay, up to one year</time_frame>
    <description>Discharge disposition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discharge outcome - readiness</measure>
    <time_frame>Acute hospital stay, up to one year</time_frame>
    <description>Timing of readiness for discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discharge outcome - length of stay</measure>
    <time_frame>Acute hospital stay, up to one year</time_frame>
    <description>Length of stay in hospital. From date of admission to date of discharge.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>Early mobilization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Late mobilization</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Early Mobilization</intervention_name>
    <description>Range of motion exercises of the upper extremity will be performed under the guidance of the physical therapy team starting on post-operative day 1.</description>
    <arm_group_label>Early mobilization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Late Mobilization</intervention_name>
    <description>The patient's grafted upper extremity will be immobilized using an elbow flexion blocking splint until post-operative day 5.</description>
    <arm_group_label>Late mobilization</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 18 years and older at the time of surgery.

          2. Injury: Acute (within 72h of injury) thermal flame or scald burn.

          3. Surgery: Skin split-thickness meshed autograft (STSG) applied directly on the wound
             bed.

          4. Location: Upper extremity burn - distal to the axilla and proximal to the wrist.

        Exclusion Criteria:

          1. Injury: Electrical and chemical burn.

          2. Location: Autograft exclusively to the wrist, hand, axilla or non-upper extremity.

          3. Patients on vasopressors the day of the operation.

          4. Pre-existing comorbidities causing upper extremity mobility restrictions.

          5. Patient unable to comply with mobilization protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shahriar Shahrokhi, MD</last_name>
    <phone>416-480-5554</phone>
    <email>shar.shahrokhi@sunnybrook.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>September 20, 2018</study_first_submitted>
  <study_first_submitted_qc>October 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 18, 2019</study_first_posted>
  <last_update_submitted>October 16, 2019</last_update_submitted>
  <last_update_submitted_qc>October 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sunnybrook Health Sciences Centre</investigator_affiliation>
    <investigator_full_name>Dr. Shahriar Shahrokhi</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

